Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.
暂无分享,去创建一个
Andrew W. Greaves | Emanuela M. Ghia | J. Byrd | J. Gribben | L. Rassenti | E. Ghia | G. Widhopf | T. Kipps | K. Rai | Sonia Jain | M. Keating | Jennifer R. Brown | N. Kay | W. Wierda
[1] J. Byrd,et al. Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3. , 2005, Blood.
[2] M. Lefranc. IMGT, the international ImMunoGeneTics information system for Immunoinformatics. Methods for querying IMGT databases, tools, and Web resources in the context of immunoinformatics. , 2008, Methods in molecular biology.
[3] E. Ghia,et al. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. , 2007, Blood.
[4] Nikolaos Laoutaris,et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. , 2006, Blood.
[5] K. Stamatopoulos,et al. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia , 2007, Leukemia.
[6] David Nemazee,et al. Receptor editing in lymphocyte development and central tolerance , 2006, Nature Reviews Immunology.
[7] Emili Montserrat,et al. IGHV gene insertions and deletions in chronic lymphocytic leukemia: “CLL‐biased” deletions in a subset of cases with stereotyped receptors , 2006, European journal of immunology.
[8] H. Döhner,et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. , 2005, Blood.
[9] E. Solary,et al. Comprehensive characterization of IGHV 3-21 – expressing B-cell chronic lymphocytic leukemia : an Italian multicenter study , 2006 .
[10] Richard Rosenquist,et al. Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia. , 2005, Blood.
[11] Nikolaos Laoutaris,et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. , 2005, Blood.
[12] Jérôme Lane,et al. IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..
[13] K. Stamatopoulos,et al. Analysis of Expressed and Non-Expressed IGK Locus Rearrangements in Chronic Lymphocytic Leukemia , 2005, Molecular medicine.
[14] E. Montserrat,et al. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. , 2005, Haematologica.
[15] D. Nemazee,et al. The scope of receptor editing and its association with autoimmunity. , 2004, Current opinion in immunology.
[16] J. Gribben,et al. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. , 2004, Blood.
[17] Arthur Weiss,et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. , 2004, The New England journal of medicine.
[18] Marie-Paule Lefranc,et al. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor VJ and VDJrearrangement analysis , 2004, Nucleic Acids Res..
[19] G. Tobin. The Immunoglobulin genes and Chronic Lymphocytic , 2004 .
[20] G. Niedobitek,et al. Rare detection of phenotypically immature lymphocytes in Hashimoto thyroiditis and rheumatoid arthritis , 2004 .
[21] Marie-Paule Lefranc,et al. IMGT, The International ImMunoGeneTics Information System, http://imgt.cines.fr. , 2004, Methods in molecular biology.
[22] F. Ajchenbaum‐Cymbalista,et al. Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] H. Stein,et al. Receptor revision of immunoglobulin heavy chain genes in human MALT lymphomas , 2003, Molecular pathology : MP.
[24] D. Gilden,et al. Single-Cell Repertoire Analysis Demonstrates that Clonal Expansion Is a Prominent Feature of the B Cell Response in Multiple Sclerosis Cerebrospinal Fluid 1 , 2003, The Journal of Immunology.
[25] G. Juliusson,et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. , 2003, Blood.
[26] M. Radic,et al. Regulation of anti-phosphatidylserine antibodies. , 2003, Immunity.
[27] M. Weigert,et al. Anti–DNA B Cells in MRL/lpr Mice Show Altered Differentiation and Editing Pattern , 2002, The Journal of experimental medicine.
[28] Arthur Weiss,et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. , 2002, Blood.
[29] Chad W. Euler,et al. Evolution of Autoantibody Responses via Somatic Hypermutation Outside of Germinal Centers , 2002, Science.
[30] A. Pettitt,et al. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. , 2002, Blood.
[31] Axel Benner,et al. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. , 2002, Blood.
[32] D. Oscier,et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. , 2002, Blood.
[33] B. Cauwelier,et al. Do B-cell chronic lymphocytic leukemia patients with Ig VH3-21 genes constitute a new subset of chronic lymphocytic leukemia? , 2002, Blood.
[34] Göran Roos,et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. , 2002, Blood.
[35] K. Toellner,et al. Low-level Hypermutation in T Cell–independent Germinal Centers Compared with High Mutation Rates Associated with T Cell–dependent Germinal Centers , 2002, The Journal of experimental medicine.
[36] M. Weigert,et al. Autoreactive B Cells in the Marginal Zone that Express Dual Receptors , 2002, The Journal of experimental medicine.
[37] M. Radic,et al. Editors and editing of anti-DNA receptors. , 2001, Immunity.
[38] A. Tefferi,et al. Analysis of clonal B‐cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B‐chronic lymphocytic leukaemia , 2001, British journal of haematology.
[39] A. Pettitt,et al. CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. , 2001, Blood.
[40] R. Rosenquist,et al. CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. , 2001, Blood.
[41] M. van der Burg,et al. Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. , 2001, Blood.
[42] F. Deist,et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[43] R. Tibshirani,et al. The Inference of Antigen Selection on Ig Genes1 , 2000, The Journal of Immunology.
[44] E. Meffre,et al. Immunoglobulin Heavy Chain Variable Region Gene Replacement as a Mechanism for Receptor Revision in Rheumatoid Arthritis Synovial Tissue B Lymphocytes , 2000, The Journal of experimental medicine.
[45] D. Nemazee,et al. B‐cell antigen receptor competence regulates B‐lymphocyte selection and survival , 2000, Immunological reviews.
[46] Mitzi Waltz,et al. Webster's New World Medical Dictionary , 2000 .
[47] K. Rajewsky,et al. Ig-α Cytoplasmic Truncation Renders Immature B Cells More Sensitive to Antigen Contact , 1999 .
[48] R. Torres,et al. A Negative Regulatory Role for Ig-α during B Cell Development , 1999 .
[49] T J Hamblin,et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.
[50] N. Chiorazzi,et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.
[51] K. Rajewsky,et al. Ig-alpha cytoplasmic truncation renders immature B cells more sensitive to antigen contact. , 1999, Immunity.
[52] R. Torres,et al. A negative regulatory role for Ig-alpha during B cell development. , 1999, Immunity.
[53] P. Lipsky,et al. Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus. , 1998, The Journal of clinical investigation.
[54] D. Nemazee,et al. Receptor editing and commitment in B lymphocytes. , 1998, Current opinion in immunology.
[55] E L Sonnhammer,et al. Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. , 1997, Journal of molecular biology.
[56] L. Rassenti,et al. Lack of Allelic Exclusion in B Cell Chronic Lymphocytic Leukemia , 1997, The Journal of experimental medicine.
[57] L. Rassenti,et al. Analysis of Immunoglobulin VH Gene Repertoire by an Anchored PCR‐Elisa a , 1995, Annals of the New York Academy of Sciences.
[58] T. Kipps,et al. Autoantibody-encoding kappa L chain genes frequently rearranged in lambda L chain-expressing chronic lymphocytic leukemia. , 1991, Journal of immunology.
[59] E. Kabat,et al. Sequences of proteins of immunological interest , 1991 .